[Excerpt] NBC News reported the family’s attorney said the boy received multiple sessions for sleep apnea and attention-deficit/hyperactivity disorder. These conditions aren’t among those approved by the U.S. Food and Drug Administration for marketing of hyperbaric oxygen therapy treatment — a fact reiterated by Nessel, who described the boy’s treatment as “unsupported by medical science.”